This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walochnik, J.
Right arrow Articles by Aspöck, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walochnik, J.
Right arrow Articles by Aspöck, H.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2008, p. 338-340, Vol. 46, No. 1
0095-1137/08/$08.00+0     doi:10.1128/JCM.01177-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Granulomatous Amoebic Encephalitis Caused by Acanthamoeba Amoebae of Genotype T2 in a Human Immunodeficiency Virus-Negative Patient{triangledown}

Julia Walochnik,1* Alexander Aichelburg,2 Ojan Assadian,3 Andrea Steuer,2 Govinda Visvesvara,4 Norbert Vetter,2 and Horst Aspöck1

Department of Medical Parasitology,1 Department of Hospital Hygiene, Clinical Institute of Hygiene and Medical Microbiology, Medical University of Vienna, Vienna, Austria,3 2nd Medical Department, Pulmonological Centre SMZ Baumgartner Höhe, Otto Wagner-Hospital, Vienna, Austria,2 Division of Parasitic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia4

Received 12 June 2007/ Returned for modification 18 October 2007/ Accepted 31 October 2007


arrow
ABSTRACT
 
Acanthamoeba amoebae of genotype T2 were identified as the causative agent of Acanthamoeba skin lesions and granulomatous amoebic encephalitis (GAE) in a human immunodeficiency virus-negative patient with underlying tuberculosis. To our knowledge this, is the first case of GAE involving genotype T2.


arrow
TEXT
 
Acanthamoebae are the causative agents of Acanthamoeba keratitis and granulomatous amebic encephalitis (GAE), a condition that predominantly occurs in immunocompromised individuals. In GAE the skin and the olfactory neuroepithelium probably function as portals of entry, and occasionally, inflammation can be observed at these primary foci. Descriptions of approximately 150 cases of GAE caused by Acanthamoeba have been published worldwide, and less than 10 of these patients have survived (9). Recently, the first case of GAE in Austria was diagnosed (A. Aichelburg et al., submitted for publication). The patient was a 25-year-old man from India with respiratory and neurological symptoms and widespread granulomatous dermal lesions. He had a CD4+ count of 182 cells/µl but was negative for human immunodeficiency virus (HIV). The final diagnosis included miliary tuberculosis, tuberculous meningitis, GAE, and Acanthamoeba skin lesions. The patient did not improve after tuberculostatic treatment or treatment with streptomycin, fluconazole, trimethoprim-sulfamethoxazole, amphotericin B, flucytosine, and sulfadiazine, which are drugs that are potentially effective against Acanthamoeba. However, he was finally treated successfully with oral and topical miltefosine and intrathecal and intravenous amikacin.

Altogether six cerebrospinal fluid (CSF) samples, two dermal punch biopsy specimens, one bronchoalveolar lavage (BAL) specimen, one lung tissue biopsy specimen, one liver tissue biopsy specimen, and one biopsy specimen from the main brain lesion were investigated for acanthamoebae by lactophenol cotton blue (LPCB) staining (15), culture, and PCR. For culture, specimens were inoculated onto the centers of nonnutrient agar plates (1.5%) precoated with Escherichia coli. The plates were sealed with Parafilm, incubated at 30°C for 14 days, and examined every 48 h. For PCR, whole-cell DNA was isolated as described previously (19) and a fragment of the 18S rRNA gene was amplified with primers JDP1 and JDP2 (8). Acanthamoeba sp. strain ATCC PRA-105, genotype T4, was used as a positive control. The amplicons were sequenced with a 310 ABI Prism automated sequencer (Applied Biosystems, Langen, Germany), and the sequences of both strands were obtained. Multiple-sequence alignment was performed with the Clustal X application (16) but with the primer sites excluded from the analysis. Genotypes were assessed with the model assumption of a <5% sequence dissimilarity within one genotype (5). The lung, liver, and brain biopsy specimens were also examined by immunofluorescence staining with polyclonal rabbit anti-Acanthamoeba castellanii serum at dilutions of 1:50 and 1:100. Sequential patient serum samples at dilutions ranging from 1:5 to 1:4,000 were tested for anti-Acanthamoeba immunoglobulin G (IgG) and IgM antibodies by immunoblotting, as described previously (20), by using the antigens of all three Acanthamoeba groups (for group I, strain Am23; for group II, strain ATCC PRA-105; for group III, strain ATCC 50704). Pooled serum from 10 healthy individuals was used as a negative control. Drug susceptibility assays were carried out at 30°C in microtiter plates with 105 trophozoites (strain ATCC PRA-105) per well. Antimicrobials were used at the following final concentrations (corresponding to the concentrations suggested for treatment): 250 mg/ml for amikacin, 5 mg/ml for amphotericin B, 7 mg/ml for caspofungin, 2 mg/ml for fluconazole, 10 mg/ml for flucytosine, 60 mg/ml for rifampin, 250 mg/ml for streptomycin, 100 mg/ml for sulfadiazine, and 10 mg/ml for voriconazole. The viability of the amoebae, as determined by phase-contrast microscopy, was recorded after 24 h; and 100% eradication was confirmed by transferring the respective suspension to E. coli-coated plates and recording the amoebal growth for 14 days. Assays were performed in two independent experiments, each time in triplicate.

The LPCB staining, culture, and immunofluorescence results were consistently negative. However, the first four CSF samples, dermal specimens, the BAL specimen, and the lung and brain tissue biopsy specimens were positive by the Acanthamoeba-specific PCR. Sequencing identified the causative agent ("strain" BS04) as Acanthamoeba genotype T2. All sequences obtained were identical. In cluster analysis, BS04 clusters with strain CCAP 1501/3c (GenBank accession no. AF019051) (Fig. 1). The liver biopsy sample and the two final CSF samples, obtained 5 and 9 months after admission to the hospital, respectively (both after therapy), were negative. Serological testing revealed a high IgG titer (1:2,000) and, in particular, a high IgM titer (1:1,000) in a serum sample obtained 3 days after admission to the hospital; the titers then gradually declined in consecutive serum samples and became comparable to those in the negative control sample (IgM titer, 1:125) after 1 year. Interestingly, the patient showed the highest immunoreactivity against Acanthamoeba morphological group III (corresponding to genotype T2). Since the patient did not show any improvement even after treatment with drugs that had been shown to be useful in previously published cases of successful treatment, miltefosine (18) and amikacin were finally used to successfully treat our patient.


Figure 1
View larger version (13K):
[in this window]
[in a new window]

  		FIG. 1. Maximum-likelihood cluster analysis of the sequence obtained and the sequences of various Acanthamoeba strains, with special reference to genotype T2 and by the use of Acanthamoeba genotypes 7, 8, and 9 as outgroups. BS04 is the sequence from the case presented here. Bootstrap values are based on 100 replicates and are given at the nodes (for maximum likelihood/neighbor joining/maximum parsimony). The designations after the genotype or strain names are GenBank accession numbers. The asterisk indicates values below 50%.

In the present case, three aspects are of particular interest: (i) the coinfection with Mycobacterium tuberculosis, (ii) the fact that acanthamoebae were detectable only by PCR while the culture result remained negative, and (iii) the fact that the acanthamoebae were genotype T2 and not genotype T4, the genotype commonly associated with disease.

Coinfection with M. tuberculosis not only is important as the reason for the severe immunosuppression of our patient (thus having contributed to the establishment of the Acanthamoeba infection) but also is important because acanthamoebae can act as hosts for mycobacteria, protecting them from antibiotics and disinfectants and even increasing their virulence (1, 4, 7). Other cases of Acanthamoeba-Mycobacterium coinfections have been reported, but these affected AIDS patients (13).

The fact that the culture result was consistently negative is not entirely unexpected, as acanthamoebae usually reside deep in the tissue, mainly around blood vessels, and their isolation from CSF is generally uncommon (2, 13). It is tempting to speculate that this is particularly true for non-AIDS patients, where amoebae cannot disseminate ad libitum. When the biopsy sample was obtained from the present case, the CD4+ counts had already reached 421 cells/µl. As the location of the lesion obviated a total excision, the site of active infection was probably missed. This would also explain the negative immunofluorescence test results and highlights the importance of molecular methods in the diagnosis of Acanthamoeba infections. In a recent case of disseminated Acanthamoeba infection in an HIV-negative patient, even detailed histological analysis of multiple biopsy specimens and culture did not enable a premortem diagnosis (14).

The Acanthamoeba strain recovered from the present case was identified as genotype T2. It has been proposed that genotype T2 be subdivided into a highly pathogenic cluster and a weakly pathogenic cluster (6). The sequence of strain BS04 clusters with the weaker pathogenic subgroup, which might also have contributed to the survival of our patient. It has been shown that of the 15 Acanthamoeba genotypes, genotype T4 is the predominant genotype in GAE (as well as in Acanthamoeba keratitis), followed by genotypes T1, T10, and T12 (3). The last two genotypes also correspond to morphological group III, as does genotype T2. A recent study revealed that while in the United Kingdom genotype T4 is the most abundant genotype, genotype T2 predominates in environmental samples in Iran (6). Our patient, who originated from India, might have acquired his infection outside Europe, and in this respect it is interesting to note that several GAE cases in HIV-negative patients have been reported from India, while in Europe and the United States GAE is mostly linked to AIDS (10-12, 17).

Nucleotide sequence accession number. The sequence data were deposited in the GenBank database and are available under accession number EF428121.


arrow
ACKNOWLEDGMENTS
 
We thank Susanne Glöckl and Iveta Häfeli (Department of Medical Parasitology, Clinical Institute of Hygiene and Medical Microbiology, Vienna, Austria) and Rama Sriram (CDC, Atlanta, GA) for excellent technical assistance.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Medical Parasitology, Clinical Institute of Hygiene and Medical Microbiology, Medical University of Vienna, Kinderspitalgasse 15, 1095 Vienna, Austria. Phone: (43) 1-40490-79446. Fax: (43) 1-40490-79435. E-mail: julia.walochnik{at}meduniwien.ac.at Back

{triangledown} Published ahead of print on 14 November 2007. Back


arrow
REFERENCES
 
    1
  1. Adekambi, T., S. Ben Salah, M. Khlif, D. Raoult, and M. Drancourt. 2006. Survival of environmental mycobacteria in Acanthamoeba polyphaga. Appl. Environ. Microbiol. 72:5974-5981.[Abstract/Free Full Text]
    2. 2
  2. Bloch, K. C., and F. L. Schuster. 2005. Inability to make a premortem diagnosis of Acanthamoeba species infection in a patient with fatal granulomatous amebic encephalitis. J. Clin. Microbiol. 43:3003-3006.[Abstract/Free Full Text]
    3. 3
  3. Booton, G. C., G. S. Visvesvara, T. J. Byers, D. J. Kelly, and P. A. Fuerst. 2005. Identification and distribution of Acanthamoeba species genotypes associated with nonkeratitis infections. J. Clin. Microbiol. 43:1689-1693.[Abstract/Free Full Text]
    4. 4
  4. Cirillo, J. D., S. Falkow, L. S. Tompkins, and L. E. Bermudez. 1997. Interaction of Mycobacterium avium with environmental amoebae enhances virulence. Infect. Immun. 65:3759-3767.[Abstract]
    5. 5
  5. Gast, R. J., D. R. Ledee, P. A. Fuerst, and T. J. Byers. 1996. Subgenus systematics of Acanthamoeba: four nuclear 18S rDNA sequence types. J. Eukaryot. Microbiol. 43:498-504.[Medline]
    6. 6
  6. Maghsood, A. H., J. Sissons, M. Rezaian, D. Nolder, D. Warhurst, and N. A. Khan. 2005. Acanthamoeba genotype T4 from the UK and Iran and isolation of the T2 genotype from clinical isolates. J. Med. Microbiol. 54:755-759.[Abstract/Free Full Text]
    7. 7
  7. Mura, M., T. J. Bull., H. Evans, K. Sidi-Boumedine, L. McMinn, G. Rhodes, R. Pickup, and J. Hermon-Taylor. 2006. Replication and long-term persistence of bovine and human strains of Mycobacterium avium subsp. paratuberculosis within Acanthamoeba polyphaga. Appl. Environ. Microbiol. 72:854-859.[Abstract/Free Full Text]
    8. 8
  8. Schroeder, J. M., G. C. Booton, J. Hay, I. A. Niszl, D. V. Seal, M. B. Markus, P. A. Fuerst, and T. J. Byers. 2001. Use of subgenic 18S ribosomal DNA PCR and sequencing for genus and genotype identification of acanthamoebae from humans with keratitis and from sewage sludge. J. Clin. Microbiol. 39:1903-1911.[Abstract/Free Full Text]
    9. 9
  9. Schuster, F. L., and G. S. Visvesvara. 2004. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Int. J. Parasitol. 34:1001-1027.[CrossRef][Medline]
    10. 10
  10. Sharma, P. P., P. Gupta, M. V. Murali, and V. G. Ramachandran. 1993. Primary amebic meningoencephalitis caused by Acanthamoeba: successfully treated with co-trimoxazole. Indian Pediatr. 30:1219-1222.[Medline]
    11. 11
  11. Shirwadkar, C. G., R. Samant, M. Sankhe, R. Deshpande, S. Yagi, F. L. Schuster, R. Sriram, and G. S. Visvesvara. 2006. Acanthamoeba encephalitis in patient with systemic lupus, India. Emerg. Infect. Dis. 12:984-986.[Medline]
    12. 12
  12. Singhal, T., A. Bajpai, V. Kalra, S. K. Kabra, J. C. Samantaray, G. Satpathy, and A. K. Gupta. 2001. Successful treatment of Acanthamoeba meningitis with combination oral antimicrobials. Pediatr. Infect. Dis. J. 20:623-627.[CrossRef][Medline]
    13. 13
  13. Sison, J. P., C. A. Kemper, M. Loveless, D. McShane, G. S. Visvesvara, and S. C. Deresinski. 1995. Disseminated Acanthamoeba infection in patients with AIDS: case reports and review. Clin. Infect. Dis. 20:1207-1216.[Medline]
    14. 14
  14. Steinberg, J. P., R. L. Galindo, E. S. Kraus, and K. G. Ghanem. 2002. Disseminated acanthamebiasis in a renal transplant recipient with osteomyelitis and cutaneous lesions: case report and literature review. Clin. Infect. Dis. 35:e43-e49.[CrossRef][Medline]
    15. 15
  15. Thomas, P. A., and T. Kuriakose. 1990. Rapid detection of Acanthamoeba cysts in corneal scrapings by lactophenol cotton blue staining. Arch. Ophthalmol. 108:168.[Abstract/Free Full Text]
    16. 16
  16. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The CLUSTAL_X Windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25:4876-4882.[Abstract/Free Full Text]
    17. 17
  17. Velho, V., G. K. Sharma, and D. A. Palande. 2003. Cerebrospinal acanthamebic granulomas. Case report. J. Neurosurg. 99:572-574.[Medline]
    18. 18
  18. Walochnik, J., M. Duchene, K. Seifert, A. Obwaller, T. Hottkowitz, G. Wiedermann, A. Eibl, and H. Aspock. 2002. Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp. Antimicrob. Agents Chemother. 46:695-701.[Abstract/Free Full Text]
    19. 19
  19. Walochnik, J., A. Hassl, K. Simon, G. Benyr, and H. Aspock. 1999. Isolation and identification by partial sequencing of the 18S ribosomal gene of free-living amoebae from necrotic tissue of Basilliscus plumifrons (Sauria: Iguanidae). Parasitol. Res. 85:601-603.[CrossRef][Medline]
    20. 20
  20. Walochnik, J., A. Obwaller, E. M. Haller-Schober, and H. Aspock. 2001. Anti-Acanthamoeba IgG, IgM, and IgA immunoreactivities in correlation to strain pathogenicity. Parasitol. Res. 87:651-656.[CrossRef][Medline]

Journal of Clinical Microbiology, January 2008, p. 338-340, Vol. 46, No. 1
0095-1137/08/$08.00+0     doi:10.1128/JCM.01177-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Kim, J.-H., Jung, S.-Y., Lee, Y.-J., Song, K.-J., Kwon, D., Kim, K., Park, S., Im, K.-I., Shin, H.-J. (2008). Effect of Therapeutic Chemical Agents In Vitro and on Experimental Meningoencephalitis Due to Naegleria fowleri. Antimicrob. Agents Chemother. 52: 4010-4016 [Abstract] [Full Text]  
  • Eddyani, M., De Jonckheere, J. F., Durnez, L., Suykerbuyk, P., Leirs, H., Portaels, F. (2008). Occurrence of Free-Living Amoebae in Communities of Low and High Endemicity for Buruli Ulcer in Southern Benin. Appl. Environ. Microbiol. 74: 6547-6553 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walochnik, J.
Right arrow Articles by Aspöck, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walochnik, J.
Right arrow Articles by Aspöck, H.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»